3 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Exonhit: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center Alzheimer's Disease, Mild Cognitive Impairment | Completed | Exonhit | 160 | 2011-11-01 | 2012-07-06 | |
| A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease EHT 0202 etazolate, Placebo - Alzheimer's Disease | Phase 2 | Completed | Exonhit | 197 | 2008-04-01 | 2009-09-21 |
| Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia Blood sampling - Alzheimer's Disease, Dementia | Not applicable | Completed | Exonhit | 550 | 2008-02-01 | 2011-03-31 |
Alzheimer Disease (3) · Dementia, Vascular (2) · Disease (2) · Mixed Dementias (2) · Aphasia, Primary Progressive (1) · Cognitive Dysfunction (1) · Dementia (1) · Frontotemporal Dementia (1) · Lewy Body Disease (1)
Blood Specimen Collection (1) · Etazolate (1)
France (2) · United States (1)
Bruno Vellas, MD (2) · Charles B. Bernick, MD (1)